Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
Abstract Purpose The human EGFR2 (HER2) signaling pathway is one of the most actively studied targets in cancer transformation research. Ttriplex-forming oligonucleotides (TFOs) activate DNA damage and induce apoptosis. We aim to encapsulate TFO-HER2 with nano-particle ZW-128 to suppress breast cell...
Main Authors: | Xiaojing Yang, Yi Xu, Jie Fu, Zan Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11176-8 |
Similar Items
-
Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates
by: Hanah F. Huber, et al.
Published: (2021-10-01) -
HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment
by: Leopoldo Sitia, et al.
Published: (2022-05-01) -
HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
by: Mengting Wang, et al.
Published: (2022-09-01) -
Effect of Hydrophobic Polypeptide Length on Performances of Thermo-Sensitive Hydrogels
by: Jiandong Han, et al.
Published: (2018-04-01) -
Novel HER-2 Targeted Therapies in Breast Cancer
by: Catarina Lopes Fernandes, et al.
Published: (2023-12-01)